Biotechnology

Proteomics Market was valued at US$ 27.07 Billion in 2022 and is expected to reach to US$ 75.03 Billion by 2030; it is estimated to record a CAGR of 13.6% from 2022 to 2030

• Biotechnology

Proteomics Market was valued at US$ 27.07 Billion in 2022 and is expected to reach to US$ 75.03 Billion by 2030; it is estimated to record a CAGR of 13.6% from 2022 to 2030

Market News Insights December 6, 2024

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis,...

Read More Read more about Proteomics Market was valued at US$ 27.07 Billion in 2022 and is expected to reach to US$ 75.03 Billion by 2030; it is estimated to record a CAGR of 13.6% from 2022 to 2030

Animal Genetics Market was valued at US$ 6,132.64 Million in 2022 and is expected to reach to US$ 8,941.90 Million by 2028; it is estimated to record a CAGR of 6.5% from 2022 to 2028

• Biotechnology

Animal Genetics Market was valued at US$ 6,132.64 Million in 2022 and is expected to reach to US$ 8,941.90 Million by 2028; it is estimated to record a CAGR of 6.5% from 2022 to 2028

Market News Insights December 4, 2024

North America is the most significant region in the global animal genetics market, and the US holds...

Read More Read more about Animal Genetics Market was valued at US$ 6,132.64 Million in 2022 and is expected to reach to US$ 8,941.90 Million by 2028; it is estimated to record a CAGR of 6.5% from 2022 to 2028

Patient-Derived Xenograft Model Market was valued at US$ 378.46 Million in 2022 and is expected to reach to US$ 975.31 Million by 2030; it is estimated to record a CAGR of 12.6% from 2022 to 2030

• Biotechnology

Patient-Derived Xenograft Model Market was valued at US$ 378.46 Million in 2022 and is expected to reach to US$ 975.31 Million by 2030; it is estimated to record a CAGR of 12.6% from 2022 to 2030

Market News Insights December 3, 2024

Patient-derived xenograft (PDX) model is a preclinical research tool used in cancer research and drug development. These...

Read More Read more about Patient-Derived Xenograft Model Market was valued at US$ 378.46 Million in 2022 and is expected to reach to US$ 975.31 Million by 2030; it is estimated to record a CAGR of 12.6% from 2022 to 2030

Gene Therapy Market was valued at US$ 5.11 Billion in 2023 and is expected to reach to US$ 25.69 Billion by 2031; it is estimated to record a CAGR of 14.3% from 2023 to 2031

• Biotechnology

Gene Therapy Market was valued at US$ 5.11 Billion in 2023 and is expected to reach to US$ 25.69 Billion by 2031; it is estimated to record a CAGR of 14.3% from 2023 to 2031

Market News Insights November 15, 2024

Gene therapy is a pioneering treatment method that uses genes to treat diseases. Gene therapy offers a...

Read More Read more about Gene Therapy Market was valued at US$ 5.11 Billion in 2023 and is expected to reach to US$ 25.69 Billion by 2031; it is estimated to record a CAGR of 14.3% from 2023 to 2031

Antibody Discovery Market was valued at US$ 2.94 Billion in 2022 and is expected to reach to US$ 4.92 Billion by 2030; it is estimated to record a CAGR of 6.7% from 2022 to 2030

• Biotechnology

Antibody Discovery Market was valued at US$ 2.94 Billion in 2022 and is expected to reach to US$ 4.92 Billion by 2030; it is estimated to record a CAGR of 6.7% from 2022 to 2030

Market News Insights November 14, 2024

Rising Incidence of Cancer Drives Antibody Discovery Market As per the Global Cancer Observatory (GLOBOCAN) estimates published...

Read More Read more about Antibody Discovery Market was valued at US$ 2.94 Billion in 2022 and is expected to reach to US$ 4.92 Billion by 2030; it is estimated to record a CAGR of 6.7% from 2022 to 2030

Gallium-68 Market was valued at US$ 782.36 Million in 2022 and is expected to reach to US$ 1,070.34 Million by 2030; it is estimated to record a CAGR of 4.0% from 2022 to 2030

• Biotechnology

Gallium-68 Market was valued at US$ 782.36 Million in 2022 and is expected to reach to US$ 1,070.34 Million by 2030; it is estimated to record a CAGR of 4.0% from 2022 to 2030

Market News Insights November 12, 2024

A rise in the prevalence of prostate cancer and neuroendocrine tumors, and a surge in the use...

Read More Read more about Gallium-68 Market was valued at US$ 782.36 Million in 2022 and is expected to reach to US$ 1,070.34 Million by 2030; it is estimated to record a CAGR of 4.0% from 2022 to 2030

Viral Vector Manufacturing Market was valued at US$ 1.29 Billion in 2022 and is expected to reach to US$ 5.00 Billion by 2030; it is estimated to record a CAGR of 18.4% from 2022 to 2030

• Biotechnology

Viral Vector Manufacturing Market was valued at US$ 1.29 Billion in 2022 and is expected to reach to US$ 5.00 Billion by 2030; it is estimated to record a CAGR of 18.4% from 2022 to 2030

Market News Insights November 5, 2024

Asia Pacific is the fastest-growing market for viral vector manufacturing. In 2022, North America held the largest...

Read More Read more about Viral Vector Manufacturing Market was valued at US$ 1.29 Billion in 2022 and is expected to reach to US$ 5.00 Billion by 2030; it is estimated to record a CAGR of 18.4% from 2022 to 2030

Upstream Bioprocessing Market was valued at US$ 9,174.09 Million in 2022 and is expected to reach to US$ 25,046.69 Million by 2030; it is estimated to record a CAGR of 13.4% from 2022 to 2030

• Biotechnology

Upstream Bioprocessing Market was valued at US$ 9,174.09 Million in 2022 and is expected to reach to US$ 25,046.69 Million by 2030; it is estimated to record a CAGR of 13.4% from 2022 to 2030

Market News Insights October 31, 2024

North America accounted for the largest share of the global upstream bioprocessing market in 2022. The market...

Read More Read more about Upstream Bioprocessing Market was valued at US$ 9,174.09 Million in 2022 and is expected to reach to US$ 25,046.69 Million by 2030; it is estimated to record a CAGR of 13.4% from 2022 to 2030

Microcarriers Market was valued at US$ 1,625.84 Million in 2022 and is expected to reach to US$ 4,178.86 Million by 2030; it is estimated to record a CAGR of 12.5% from 2022 to 2030

• Biotechnology

Microcarriers Market was valued at US$ 1,625.84 Million in 2022 and is expected to reach to US$ 4,178.86 Million by 2030; it is estimated to record a CAGR of 12.5% from 2022 to 2030

Market News Insights October 22, 2024

Automation of Cell and Gene Therapy Manufacturing Services Emerging as New Trend in Microcarriers Market Incorporating automation...

Read More Read more about Microcarriers Market was valued at US$ 1,625.84 Million in 2022 and is expected to reach to US$ 4,178.86 Million by 2030; it is estimated to record a CAGR of 12.5% from 2022 to 2030

Molecular Spectroscopy Market was valued at US$ 3,807.30 Million in 2022 and is expected to reach to US$ 5,586.37 Million by 2030; it is estimated to record a CAGR of 4.9% from 2022 to 2030

• Biotechnology

Molecular Spectroscopy Market was valued at US$ 3,807.30 Million in 2022 and is expected to reach to US$ 5,586.37 Million by 2030; it is estimated to record a CAGR of 4.9% from 2022 to 2030

Market News Insights October 15, 2024

The demand for and use of molecular spectroscopy increased significantly during the COVID-19 pandemic. In July 2022,...

Read More Read more about Molecular Spectroscopy Market was valued at US$ 3,807.30 Million in 2022 and is expected to reach to US$ 5,586.37 Million by 2030; it is estimated to record a CAGR of 4.9% from 2022 to 2030